US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Binah Capital Group Inc

2.07

-0.0420-1.99%

Post-market: 2.070.00000.00%16:04 EST

Volume:14.80K

Turnover:30.23K

Market Cap:34.33M

PE:55.56

High:2.10

Open:2.03

Low:1.90

Close:2.11

52wk High:3.44

52wk Low:1.36

Shares:16.60M

Float Shares:3.04M

Volume Ratio:2.35

T/O Rate:0.49%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0372

EPS(LYR):-0.3189

ROE:5.88%

ROA:1.56%

PB:30.77

PE(LYR):-6.48

Loading ...

Overview Company News Filings

AI Enables "Extracting More Value from Fewer Junior Staff" – McKinsey and Other Consulting Giants Freeze Starting Salaries for Third Consecutive Year

Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025

Binah Capital Group to Present at NobleCon21 Emerging Growth Equity Conference

Baltic Classifieds Group Plc (BCG) was downgraded to a Sell Rating at J.P. Morgan

Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC Amidst BCG Shortages

Binah Capital Group CEO Craig Gould Acquires Common Shares

BUZZ-U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital

Treasure Global's Subsidiary Tadaa Technologies Appointed Exclusive Partner and Treasury Manager for 200 Million UNIRWA Tokens, Projected Value USD 100 Million

Why Is Cidara Therapeutics (CDTX) Stock Trending Overnight?

Why Binah Capital (BCG) Stock Jumped 75% In After-Hours Trading

Binah Capital Group Inc - Qtrly Total Revenue $46.2 Mln

THOMSON REUTERS

Binah Capital Group reports third quarter revenue of $137 million and net income of $2.1 million

Press Release: ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team

Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update

Press Release: Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Press Release: Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024

Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace

Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer

Entry-Level Consulting Jobs May Be Replaced by AI as Former McKinsey Employees Hired to Train Models

Aptos Labs, in collaboration with Boston Consulting Group and Hang Seng Bank, has completed a pilot and research study on "Cyberport Dollar+" (a digital currency initiative). Over 60% of the investors are planning to double down on the tokenized fund.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCG/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCG\",,,,,undefined,":{"symbol":"BCG","market":"US","secType":"STK","nameCN":"Binah Capital Group Inc","latestPrice":2.068,"timestamp":1772571600000,"preClose":2.11,"halted":0,"volume":14803,"hourTrading":{"tag":"盘后","latestPrice":2.068,"preClose":2.068,"latestTime":"16:04 EST","volume":3,"amount":6.24,"timestamp":1772571868347,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019905213270142094,"floatShares":3036659,"shares":16602460,"eps":0.03722,"marketStatus":"Closed","change":-0.042,"latestTime":"03-03 16:00:00 EST","open":2.03,"high":2.1,"low":1.9,"amount":30227.3389,"amplitude":0.094787,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.03722,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772614800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":2.11,"postHourTrading":{"tag":"盘后","latestPrice":2.068,"preClose":2.068,"latestTime":"16:04 EST","volume":3,"amount":6.24,"timestamp":1772571868347,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.346331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCG\",,,,,undefined,":{"symbol":"BCG","floatShares":3036659,"roa":"1.56%","roe":"5.88%","lyrEps":-0.318929,"volumeRatio":2.346331,"shares":16602460,"dividePrice":0,"high":2.1,"amplitude":0.094787,"preClose":2.11,"low":1.9,"week52Low":1.36,"pbRate":"30.77","psRate":"0.19","week52High":3.44,"institutionHeld":0,"latestPrice":2.068,"eps":0.03722,"divideRate":0,"volume":14803,"delay":0,"ttmEps":0.03722,"open":2.03,"prevYearClose":2.88,"prevWeekClose":2.15,"prevMonthClose":2.15,"prevQuarterClose":2.88,"fiveDayClose":2.1,"twentyDayClose":2.45,"sixtyDayClose":2.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"BCG","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":0.08},{"market":"US","date":"2025-08-13","symbol":"BCG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCG\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCG","date":"2026-03-02","current":55.561526,"percent":0.792123,"low":-94.684933,"twenty":-18.070481,"median":-11.663455,"eighty":35.014366,"high":216.897522,"avg":2.796788,"sd":47.469897,"marketCap":35695289},"quantilePoints":[{"date":"2024-04-12","current":47.846282,"twenty":47.314657,"median":50.799756,"eighty":52.276493,"marketCap":133339024},{"date":"2024-04-19","current":40.132439,"twenty":41.297957,"median":46.73873,"eighty":50.917895,"marketCap":111841925},{"date":"2024-04-26","current":203.935518,"twenty":44.420253,"median":50.799756,"eighty":187.977853,"marketCap":116447181},{"date":"2024-05-03","current":181.468046,"twenty":45.542573,"median":118.644354,"eighty":199.211588,"marketCap":103618254},{"date":"2024-05-10","current":158.424485,"twenty":47.403261,"median":158.424485,"eighty":194.026786,"marketCap":90460381},{"date":"2024-05-17","current":135.380923,"twenty":48.08256,"median":150.76106,"eighty":191.347973,"marketCap":77302507},{"date":"2024-05-24","current":216.897522,"twenty":50.268131,"median":142.815352,"eighty":191.347973,"marketCap":123848485},{"date":"2024-05-31","current":-70.098677,"twenty":46.96024,"median":139.70159,"eighty":188.726768,"marketCap":145945446},{"date":"2024-06-07","current":-77.180156,"twenty":40.710114,"median":130.655552,"eighty":184.646906,"marketCap":160689084},{"date":"2024-06-14","current":-52.991736,"twenty":-57.718026,"median":121.266741,"eighty":182.34255,"marketCap":110328794},{"date":"2024-06-21","current":-39.863152,"twenty":-52.943996,"median":66.796341,"eighty":180.865278,"marketCap":82995083},{"date":"2024-06-28","current":-46.865063,"twenty":-56.142596,"median":53.605557,"eighty":179.659743,"marketCap":97573062},{"date":"2024-07-05","current":-45.194153,"twenty":-52.896255,"median":49.470693,"eighty":176.203209,"marketCap":94094226},{"date":"2024-07-12","current":-42.966272,"twenty":-51.448132,"median":45.631177,"eighty":169.370177,"marketCap":89455779},{"date":"2024-07-15","current":-46.626362,"twenty":-50.795682,"median":45.409667,"eighty":167.641909,"marketCap":97076086},{"date":"2024-08-02","current":-31.986002,"twenty":-50.143231,"median":45.188156,"eighty":165.913642,"marketCap":66594857},{"date":"2024-08-09","current":-28.166778,"twenty":-49.363473,"median":40.613835,"eighty":159.576663,"marketCap":58643232},{"date":"2024-08-16","current":-20.272151,"twenty":-47.35838,"median":-24.029285,"eighty":158.424485,"marketCap":59802844},{"date":"2024-08-23","current":-19.247598,"twenty":-46.674102,"median":-19.602159,"eighty":156.120128,"marketCap":56780413},{"date":"2024-08-30","current":-19.866672,"twenty":-46.24444,"median":-19.585275,"eighty":147.891273,"marketCap":58606683},{"date":"2024-09-06","current":-18.302664,"twenty":-45.957998,"median":-19.585275,"eighty":144.080444,"marketCap":53992860},{"date":"2024-09-13","current":-15.251751,"twenty":-45.448768,"median":-19.106899,"eighty":140.947095,"marketCap":44992666},{"date":"2024-09-20","current":-16.883858,"twenty":-45.194153,"median":-18.403405,"eighty":138.834001,"marketCap":49807380},{"date":"2024-09-27","current":-18.009448,"twenty":-45.194153,"median":-18.156337,"eighty":136.530797,"marketCap":53127872},{"date":"2024-10-04","current":-14.801515,"twenty":-45.098673,"median":-18.009448,"eighty":129.710478,"marketCap":43664469},{"date":"2024-10-11","current":-15.139192,"twenty":-44.271652,"median":-17.794742,"eighty":123.304944,"marketCap":44660617},{"date":"2024-10-18","current":-13.732204,"twenty":-43.642912,"median":-16.883858,"eighty":121.209133,"marketCap":40510002},{"date":"2024-10-25","current":-11.706141,"twenty":-43.204974,"median":-16.377341,"eighty":95.05469,"marketCap":34533116},{"date":"2024-10-31","current":-12.147373,"twenty":-41.725024,"median":-16.067805,"eighty":68.991477,"marketCap":35834749},{"date":"2024-11-08","current":-12.325216,"twenty":-38.781038,"median":-15.870826,"eighty":54.048578,"marketCap":36359387},{"date":"2024-11-15","current":-19.641554,"twenty":-35.089122,"median":-15.983385,"eighty":51.154173,"marketCap":57942585},{"date":"2024-11-22","current":-9.482521,"twenty":-31.222157,"median":-15.814546,"eighty":49.736506,"marketCap":41174100},{"date":"2024-11-29","current":-9.867391,"twenty":-29.805862,"median":-15.758267,"eighty":48.08256,"marketCap":42834346},{"date":"2024-12-06","current":-9.217214,"twenty":-28.707835,"median":-15.561288,"eighty":47.403261,"marketCap":40011928},{"date":"2024-12-13","current":-11.205991,"twenty":-28.548701,"median":-15.251751,"eighty":45.542573,"marketCap":48645207},{"date":"2024-12-20","current":-8.873003,"twenty":-28.103124,"median":-15.039858,"eighty":44.420253,"marketCap":38517707},{"date":"2024-12-27","current":-11.66494,"twenty":-27.84851,"median":-14.773376,"eighty":41.348639,"marketCap":50637503},{"date":"2025-01-03","current":-10.555814,"twenty":-27.84851,"median":-14.407558,"eighty":41.145913,"marketCap":45822789},{"date":"2025-01-10","current":-10.364586,"twenty":-27.132405,"median":-13.712083,"eighty":40.517556,"marketCap":44992666},{"date":"2025-01-17","current":-9.599672,"twenty":-25.795677,"median":-13.338247,"eighty":11.509386,"marketCap":41672174},{"date":"2025-01-24","current":-9.561426,"twenty":-24.74539,"median":-12.325216,"eighty":-7.572649,"marketCap":41506150},{"date":"2025-01-31","current":-8.069843,"twenty":-22.526431,"median":-12.059139,"eighty":-7.572649,"marketCap":35031190},{"date":"2025-02-07","current":-8.299318,"twenty":-20.109959,"median":-11.84684,"eighty":-7.649141,"marketCap":36027338},{"date":"2025-02-14","current":-7.955106,"twenty":-19.799137,"median":-11.755302,"eighty":-7.809773,"marketCap":34533116},{"date":"2025-02-21","current":-7.534404,"twenty":-19.697834,"median":-11.685541,"eighty":-7.672088,"marketCap":32706846},{"date":"2025-02-28","current":-10.976517,"twenty":-19.697834,"median":-11.593582,"eighty":-7.542053,"marketCap":47649060},{"date":"2025-03-07","current":-8.567038,"twenty":-19.686578,"median":-11.300169,"eighty":-7.572649,"marketCap":37189510},{"date":"2025-03-14","current":-7.381421,"twenty":-19.641554,"median":-11.255905,"eighty":-7.572649,"marketCap":32042747},{"date":"2025-03-21","current":-7.151947,"twenty":-19.630298,"median":-11.225114,"eighty":-7.350824,"marketCap":31046600},{"date":"2025-03-28","current":-7.687386,"twenty":-19.585275,"median":-11.1295,"eighty":-7.412018,"marketCap":33370944},{"date":"2025-04-04","current":-7.242195,"twenty":-19.569517,"median":-10.842657,"eighty":-7.32062,"marketCap":33038895},{"date":"2025-04-11","current":-6.987445,"twenty":-19.454706,"median":-10.555814,"eighty":-7.159596,"marketCap":31876723},{"date":"2025-04-17","current":-7.496946,"twenty":-19.247598,"median":-10.43842,"eighty":-7.190192,"marketCap":34201067},{"date":"2025-04-25","current":-8.006447,"twenty":-18.9662,"median":-10.135111,"eighty":-7.242195,"marketCap":36525412},{"date":"2025-05-02","current":-8.388573,"twenty":-18.90992,"median":-9.982129,"eighty":-7.266684,"marketCap":38268670},{"date":"2025-05-09","current":-7.860875,"twenty":-18.572243,"median":-9.867391,"eighty":-7.314981,"marketCap":35861313},{"date":"2025-05-16","current":-8.406769,"twenty":-18.572243,"median":-9.867391,"eighty":-7.343175,"marketCap":38351682},{"date":"2025-05-23","current":-20.369548,"twenty":-19.247598,"median":-9.867391,"eighty":-7.381421,"marketCap":39679879},{"date":"2025-05-30","current":-18.835439,"twenty":-19.522241,"median":-9.943883,"eighty":-7.381421,"marketCap":36691436},{"date":"2025-06-06","current":-18.153613,"twenty":-19.522241,"median":-10.135111,"eighty":-7.442614,"marketCap":35363239},{"date":"2025-06-13","current":-17.471788,"twenty":-19.299375,"median":-10.401503,"eighty":-7.489139,"marketCap":34035043},{"date":"2025-06-20","current":-17.216103,"twenty":-19.209964,"median":-10.536691,"eighty":-7.518782,"marketCap":33536969},{"date":"2025-06-27","current":-17.045647,"twenty":-19.179762,"median":-10.708797,"eighty":-7.533978,"marketCap":33204920},{"date":"2025-07-03","current":-17.045647,"twenty":-19.092292,"median":-11.091254,"eighty":-7.534404,"marketCap":33204920},{"date":"2025-07-11","current":-16.789962,"twenty":-18.947987,"median":-11.20309,"eighty":-7.549702,"marketCap":32706846},{"date":"2025-07-18","current":-18.153613,"twenty":-18.916369,"median":-11.255905,"eighty":-7.572649,"marketCap":35363239},{"date":"2025-07-25","current":-20.113863,"twenty":-19.092292,"median":-11.268602,"eighty":-7.603246,"marketCap":39181805},{"date":"2025-08-01","current":-17.812701,"twenty":-19.10817,"median":-11.511957,"eighty":-7.649141,"marketCap":34699141},{"date":"2025-08-08","current":-17.812701,"twenty":-18.990018,"median":-11.663455,"eighty":-7.664439,"marketCap":34699141},{"date":"2025-08-15","current":-18.758554,"twenty":-18.990018,"median":-11.741431,"eighty":-7.702684,"marketCap":34984703},{"date":"2025-08-22","current":-17.270119,"twenty":-18.947987,"median":-11.83277,"eighty":-7.74093,"marketCap":32208772},{"date":"2025-08-29","current":-17.448161,"twenty":-18.916369,"median":-11.970905,"eighty":-7.763878,"marketCap":32540821},{"date":"2025-09-05","current":-15.845779,"twenty":-18.895024,"median":-12.268936,"eighty":-7.76872,"marketCap":29552378},{"date":"2025-09-12","current":-16.023822,"twenty":-18.835439,"median":-13.338247,"eighty":-7.788089,"marketCap":29884428},{"date":"2025-09-19","current":-15.845779,"twenty":-18.825212,"median":-13.344354,"eighty":-7.802646,"marketCap":29552378},{"date":"2025-09-26","current":-14.866546,"twenty":-18.779152,"median":-14.013602,"eighty":-7.864423,"marketCap":27726108},{"date":"2025-10-03","current":-15.311652,"twenty":-18.721292,"median":-14.332418,"eighty":-7.878615,"marketCap":28556231},{"date":"2025-10-10","current":-14.599482,"twenty":-18.572243,"median":-14.426713,"eighty":-7.878615,"marketCap":27228034},{"date":"2025-10-17","current":-19.762714,"twenty":-18.721292,"median":-14.688503,"eighty":-7.882346,"marketCap":36857461},{"date":"2025-10-24","current":-15.756758,"twenty":-18.779152,"median":-14.78952,"eighty":-7.897268,"marketCap":29386354},{"date":"2025-10-31","current":-14.065354,"twenty":-18.721292,"median":-14.801515,"eighty":-7.901187,"marketCap":26231886},{"date":"2025-11-07","current":-13.264164,"twenty":-18.572243,"median":-14.76138,"eighty":-7.916861,"marketCap":24737665},{"date":"2025-11-14","current":-12.685525,"twenty":-18.565223,"median":-14.599482,"eighty":-7.916861,"marketCap":23658505},{"date":"2025-11-21","current":36.982534,"twenty":-18.532996,"median":-14.515289,"eighty":-7.897268,"marketCap":38683731},{"date":"2025-11-28","current":44.442532,"twenty":-18.516416,"median":-14.421885,"eighty":-7.878615,"marketCap":46486888},{"date":"2025-12-05","current":36.982534,"twenty":-18.459684,"median":-14.332418,"eighty":-7.763878,"marketCap":38683731},{"date":"2025-12-12","current":40.157001,"twenty":-18.451912,"median":-14.065354,"eighty":-7.649141,"marketCap":42004223},{"date":"2025-12-19","current":35.712749,"twenty":-18.403405,"median":-13.691962,"eighty":-7.534404,"marketCap":37355535},{"date":"2025-12-26","current":37.379343,"twenty":-18.322812,"median":-13.344354,"eighty":-7.489139,"marketCap":39098793},{"date":"2026-01-02","current":45.712317,"twenty":-18.264371,"median":-13.338247,"eighty":-7.366123,"marketCap":47815084},{"date":"2026-01-09","current":41.744234,"twenty":-18.238842,"median":-13.219653,"eighty":-7.221394,"marketCap":43664469},{"date":"2026-01-16","current":38.252321,"twenty":-18.191735,"median":-12.908079,"eighty":-7.110947,"marketCap":40011928},{"date":"2026-01-23","current":39.045938,"twenty":-18.157644,"median":-12.551994,"eighty":-7.002002,"marketCap":40842051},{"date":"2026-01-30","current":36.553982,"twenty":-18.153613,"median":-12.254677,"eighty":-6.777139,"marketCap":38235465},{"date":"2026-02-06","current":36.030195,"twenty":-18.153613,"median":-11.970905,"eighty":32.030367,"marketCap":37687584},{"date":"2026-02-13","current":32.585899,"twenty":-18.136567,"median":-11.83277,"eighty":33.940863,"marketCap":34084850},{"date":"2026-02-20","current":36.347641,"twenty":-18.103061,"median":-11.755302,"eighty":34.347728,"marketCap":38019633},{"date":"2026-02-27","current":35.077855,"twenty":-18.070896,"median":-11.66494,"eighty":35.04611,"marketCap":36691436},{"date":"2026-03-02","current":34.125515,"twenty":-18.070481,"median":-11.663455,"eighty":35.014366,"marketCap":35695289}],"updateTime":1772574800558},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCG\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135883589","title":"AI Enables \"Extracting More Value from Fewer Junior Staff\" – McKinsey and Other Consulting Giants Freeze Starting Salaries for Third Consecutive Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1135883589","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135883589?lang=en_us&edition=fundamental","pubTime":"2025-12-02 09:22","pubTimestamp":1764638567,"startTime":"0","endTime":"0","summary":"The rise of artificial intelligence is profoundly reshaping the traditional business model of the consulting industry, forcing industry giants to reconsider their talent pyramid structure, which has...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4585","BK4588","BCG","BK4543","BK4551","BK4587","BK4135","AI","BK4528"],"gpt_icon":0},{"id":"2588703578","title":"Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients on Wednesday, December 3, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588703578","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588703578?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:15","pubTimestamp":1764623700,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec.  01, 2025  (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, tod","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3197457/0/en/Protara-Therapeutics-to-Host-Conference-Call-and-Webcast-to-Review-New-Interim-Data-from-Phase-2-ADVANCED-2-Trial-of-TARA-002-in-BCG-Na%C3%AFve-NMIBC-Patients-on-Wednesday-December-3-20.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HST","BK4585","BCG","BK4588","BK4139","TARA","BK4218","BK4135","BK4181"],"gpt_icon":0},{"id":"2586408851","title":"Binah Capital Group to Present at NobleCon21 Emerging Growth Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2586408851","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586408851?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:30","pubTimestamp":1764091810,"startTime":"0","endTime":"0","summary":"Binah Capital Group Inc. will participate in the NobleCon21 conference, Noble Capital Markets' 21st Annual Emerging Growth Equity Conference, in Boca Raton, FL on December 4, 2025. Chief Executive Officer Craig Gould and Chief Financial Officer David Shane are scheduled to present for the company at 9:30 AM ET in Presentation Room 5. A webcast of the presentation will be available the following day on Binah Capital's investor relations website, the Noble Capital Markets' Conference website, and Channelchek, and will be archived for 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Binah Capital Group Inc. published the original content used to generate this news brief via GlobeNewswire  on November 25, 2025, and is solely respons","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL7tgWp9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BCG","BK4112","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","BK4135","IE00BKPKM429.USD","LU2210150020.SGD","BK4585","LU2095319765.USD","NDAQ"],"gpt_icon":0},{"id":"2586989470","title":"Baltic Classifieds Group Plc (BCG) was downgraded to a Sell Rating at J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2586989470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586989470?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:56","pubTimestamp":1764089819,"startTime":"0","endTime":"0","summary":"In a report released today, Marcus Diebel from J.P. Morgan downgraded Baltic Classifieds Group Plc to a Sell, with a price target of p194.00. Diebe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/baltic-classifieds-group-plc-bcg-was-downgraded-to-a-sell-rating-at-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/baltic-classifieds-group-plc-bcg-was-downgraded-to-a-sell-rating-at-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCG"],"gpt_icon":0},{"id":"2585933469","title":"Protara Therapeutics’ TARA-002: A Promising Alternative for NMIBC Amidst BCG Shortages","url":"https://stock-news.laohu8.com/highlight/detail?id=2585933469","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585933469?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:35","pubTimestamp":1763984155,"startTime":"0","endTime":"0","summary":"In a report released today, Andres Y. Maldonado from H.C. Wainwright reiterated a Buy rating on Protara Therapeutics, with a price target of $23.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protara-therapeutics-tara-002-a-promising-alternative-for-nmibc-amidst-bcg-shortages-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protara-therapeutics-tara-002-a-promising-alternative-for-nmibc-amidst-bcg-shortages-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCG","BK4139","TARA","BK4135"],"gpt_icon":0},{"id":"2584973929","title":"Binah Capital Group CEO Craig Gould Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584973929","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584973929?lang=en_us&edition=fundamental","pubTime":"2025-11-20 04:36","pubTimestamp":1763584584,"startTime":"0","endTime":"0","summary":"Craig Gould, Chief Executive Officer and Director, reported the acquisition of common shares of Binah Capital Group Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Binah Capital Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL3NRh4q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Binah Capital Group CEO Craig Gould Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"2583500904","title":"BUZZ-U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2583500904","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583500904?lang=en_us&edition=fundamental","pubTime":"2025-11-14 23:47","pubTimestamp":1763135267,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Molina Healthcare, Memory chip makers, Binah CapitalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning New","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL6N3WQ0UR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOM","CVX","LU0096362180.USD","CDTX","FSLR","WMT","LU0109392836.USD","RIOT","LU0306807586.USD","AVDL","FANG","LU2272731600.USD","QMCO","BK4170","BCG","SEPN","BK4106","COP","VSTM","FCX","SCCO","AMAT","AHL","LU0128525929.USD","MOH","BK4600","STRK","GAP","TMC","TRIP","IE00B3CCJ963.GBP","IE00BGHQF417.EUR","SRRK","BMY","PSFE","BK4588","NEM","LU0106831901.USD","SPCE"],"gpt_icon":1},{"id":"2583505299","title":"Treasure Global's Subsidiary Tadaa Technologies Appointed Exclusive Partner and Treasury Manager for 200 Million UNIRWA Tokens, Projected Value USD 100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583505299","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583505299?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:35","pubTimestamp":1763123700,"startTime":"0","endTime":"0","summary":"OXI Wallet Integration Targeted 1H 2026KUALA LUMPUR, Malaysia, Nov.  14, 2025  (GLOBE NEWSWIRE) -- Treasure Global Inc. (NASDAQ: TGL) (“Treasure Global” or the “Company”), a Southeast Asia–anchored te","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/14/3188232/0/en/Treasure-Global-s-Subsidiary-Tadaa-Technologies-Appointed-Exclusive-Partner-and-Treasury-Manager-for-200-Million-UNIRWA-Tokens-Projected-Value-USD-100-Million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","TGL","BK4009","BCG","USD"],"gpt_icon":0},{"id":"2583339529","title":"Why Is Cidara Therapeutics (CDTX) Stock Trending Overnight?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583339529","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583339529?lang=en_us&edition=fundamental","pubTime":"2025-11-14 13:56","pubTimestamp":1763099760,"startTime":"0","endTime":"0","summary":"Cidara Therapeutics shares jumped over 42% in after-hours trading following a 13D filing and Phase 3 enrollment milestone.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48856735/why-is-cidara-therapeutics-cdtx-stock-trending-overnight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCG","BK4135","BK4139","CDTX"],"gpt_icon":0},{"id":"2583528360","title":"Why Binah Capital (BCG) Stock Jumped 75% In After-Hours Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2583528360","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583528360?lang=en_us&edition=fundamental","pubTime":"2025-11-14 11:36","pubTimestamp":1763091415,"startTime":"0","endTime":"0","summary":"Binah Capital jumped 74.76% in after-hours trading following stronger-than-expected Q3 results.\n","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48855798/why-binah-capital-bcg-stock-jumped-75-in-after-hours-trading","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCG","BK4135"],"gpt_icon":0},{"id":"2583522543","title":"Binah Capital Group Inc - Qtrly Total Revenue $46.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2583522543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583522543?lang=en_us&edition=fundamental","pubTime":"2025-11-14 07:16","pubTimestamp":1763075805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP2C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"2583510674","title":"Binah Capital Group reports third quarter revenue of $137 million and net income of $2.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2583510674","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583510674?lang=en_us&edition=fundamental","pubTime":"2025-11-14 06:09","pubTimestamp":1763071762,"startTime":"0","endTime":"0","summary":"Binah Capital Group Inc. reported total revenue of $137.0 million for the first nine months of 2025, a 10% increase year-over-year. Assets under management grew 11% to $30.0 billion as of September 30, 2025. The company recorded a net income of $2.1 million for the first three quarters of 2025, compared to a net loss of $3.5 million in the same period in 2024. EBITDA rose to $5.8 million from $1.0 million in the prior year period. As of September 30, 2025, Binah Capital Group had cash and cash equivalents of $8.3 million and long-term debt of $18.2 million. The company attributed its performance to revenue growth and lower expenses, and highlighted ongoing momentum and expansion initiatives in its network of firms supporting independent financial advisors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nNDL7GtnhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"2582375983","title":"Press Release: ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375983","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375983?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:15","pubTimestamp":1762949700,"startTime":"0","endTime":"0","summary":"$142.6 million cash and cash equivalents and marketable securities as of September 30, 2025. Protocol amendment for ongoing Phase 2b ADAPTIVE study of IMG-007 in atopic dermatitis  announced to optimize study design in alignment with IMG-007's unique molecular attributes; strong patient enrollment continues. She continued, \"Our recent learnings reinforce our belief that the anti-OX40/OX40L class, with its unique mechanism, is on a promising path towards adoption in atopic dermatitis and other inflammatory and autoimmune indications. However, the peer data to date also highlight the need for a differentiated anti-OX40 treatment that is safe and can be administered at optimal doses for maximum efficacy. Both thoughtful study design and high-quality execution are essential to achieve success--we must 'sweat the small stuff.' We believe IMG-007 is the only anti-OX40 in mid- to late-stage clinical development that is non-T cell depleting and receptor-targeting, with a roughly 5-week half-li","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4595","AD","BK4585","BK4588","IMA","TISI","BK4023","BK4596","BK4516","BK4600","IMG","BCG","BK4135","BK4007","BK4212","BK4120","BK4132","ISDS","STRK"],"gpt_icon":1},{"id":"2582340872","title":"Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2582340872","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582340872?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779600,"startTime":"0","endTime":"0","summary":"Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025Expect to present interim analysis from approximately 25 six-month eva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/10/3184499/0/en/Protara-Therapeutics-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCG","LENZ","BK4135","BK4523","IFN","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2581726868","title":"Press Release: Recursion Announces CEO Transition Plan to Drive Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2581726868","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581726868?lang=en_us&edition=fundamental","pubTime":"2025-11-05 19:28","pubTimestamp":1762342080,"startTime":"0","endTime":"0","summary":"Salt Lake City, Utah, Nov. 05, 2025  -- Recursion , a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board of Directors has unanimously approved a leadership transition plan to become effective January 1, 2026:. -- Najat Khan, Ph.D., currently Chief R&D and Commercial Officer and a Board. Member, will succeed Co-Founder and CEO Chris Gibson, Ph.D., as Chief. Executive Officer and President. Najat will also continue in her role as. -- Chris Gibson, Ph. D., current Co-Founder and CEO, will transition to. -- Rob Hershberg, MD/Ph.D., Recursion's current Chairman, will transition to. \"I'm deeply honored that I will be stepping into the role of CEO and President and build on the remarkable foundation established by Chris Gibson and the visionary founders of Recursion,\" said Dr. Najat Khan. \"Powered by exceptional people and united by a bold mission to decode biology to radically improve patients' lives, Recursion has built somethi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4611","BK4548","BCG","BK4539","BK4609","RXRX","BK4139","BK4135"],"gpt_icon":1},{"id":"2581130597","title":"Press Release: Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2581130597","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581130597?lang=en_us&edition=fundamental","pubTime":"2025-11-05 11:12","pubTimestamp":1762312320,"startTime":"0","endTime":"0","summary":"-- Q3 2025 Revenue and Other Income Growth with Continued Strong Sales. Momentum: $33.7 million of total revenue and other income, up from $26.4. -- Product Revenue: Up 434% in Q3 2025 versus Q3 2024, with year-to-date. -- ANKTIVA Unit Growth: 467% unit sales volume growth in year-to-date. -- Cash Position: $257.8 million in cash, cash equivalents, and marketable. securities as of September 30, 2025, up from $153.7 million as of June. -- Glioblastoma: Early results from the first five recurrent glioblastoma. patients treated with ANKTIVA plus the Optune Gio device in. combination with PD-L1 CAR-NK showed 100% disease control, including. three responses  and two cases of stable disease.Lymphocyte counts increased in all five patients. Based on these findings,-- Non-Small Cell Lung Cancer : ImmunityBio has initiated enrollment. showed promising complete responses in the first two patients with. late-stage Waldenstrom macroglobulinemia treated to date using its CD19. NCCN reviewed the sub","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","03160","BK4135","BCG","IBRX","R","BK4232","BK4585","BK4555","BK4604","BK4099","TM","BK4022","BK4588"],"gpt_icon":0},{"id":"2581761892","title":"Protara Therapeutics Named a 2026 Best Places to Work Winner by BioSpace","url":"https://stock-news.laohu8.com/highlight/detail?id=2581761892","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581761892?lang=en_us&edition=fundamental","pubTime":"2025-11-05 05:05","pubTimestamp":1762290300,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  04, 2025  (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180856/0/en/Protara-Therapeutics-Named-a-2026-Best-Places-to-Work-Winner-by-BioSpace.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4135","LENZ","BK4539","BCG","BK4139"],"gpt_icon":0},{"id":"2580273561","title":"Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2580273561","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580273561?lang=en_us&edition=fundamental","pubTime":"2025-11-04 20:01","pubTimestamp":1762257660,"startTime":"0","endTime":"0","summary":"Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180169/0/en/Relmada-Announces-FDA-Feedback-Supporting-2-Separate-Acceptable-Registrational-Study-Paths-for-NDV-01-in-Non-muscle-Invasive-Bladder-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BCG"],"gpt_icon":0},{"id":"1151056530","title":"Entry-Level Consulting Jobs May Be Replaced by AI as Former McKinsey Employees Hired to Train Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1151056530","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151056530?lang=en_us&edition=fundamental","pubTime":"2025-10-30 23:51","pubTimestamp":1761839461,"startTime":"0","endTime":"0","summary":"In recent years, the consulting industry has faced numerous challenges in major markets such as the UK, Saudi Arabia, and Australia. Now, the latest threat to the sector may come from within....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4528","BCG","BK4135","BK4585","BK4543","BK4551","BK4587","BK4588","AI"],"gpt_icon":0},{"id":"2578109937","title":"Aptos Labs, in collaboration with Boston Consulting Group and Hang Seng Bank, has completed a pilot and research study on \"Cyberport Dollar+\" (a digital currency initiative). Over 60% of the investors are planning to double down on the tokenized fund.","url":"https://stock-news.laohu8.com/highlight/detail?id=2578109937","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578109937?lang=en_us&edition=fundamental","pubTime":"2025-10-28 18:34","pubTimestamp":1761647640,"startTime":"0","endTime":"0","summary":"BlockBeats News, October 28th, Aptos Labs and Boston Consulting Group  jointly released the \"Hong Kong Digital Currency and Tokenized Asset Survey\" report. The survey covered over 500 retail fund investors, of which 61% of retail investors in Hong Kong and mainland China stated their intention to increase their allocation to tokenized funds by more than double. They were mainly attracted by the higher liquidity, transparency, 24/7 trading, and programmability provided by tokenization technology.At the same time, the research further identified four typical investment groups: Hong Kong active traders expect to increase their allocation to tokenized funds from 10% to 26%, high-net-worth individuals from 5% to 16%, long-term investors from 8% to 25%, and mainland investors plan to increase from 11% to 24%.The report also summarized the participation of Aptos Labs, BCG, and HSBC in the Hong Kong Monetary Authority's \"e-Hong Kong Dollar+\" second-phase pilot. The pilot, which utilized Aptos ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/318066","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/318066","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BKKT","BK4600","APT.USD.CC","BK4135","BK4595","BCG","BK4112","APT.USD.HKCC"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":56,"code":"91000000","status":"200"}]}}